Vanguard Group Inc Igm Biosciences, Inc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 853,658 shares of IGMS stock, worth $5.83 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
853,658
Previous 897,149
4.85%
Holding current value
$5.83 Million
Previous $7.46 Million
10.49%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding IGMS
# of Institutions
90Shares Held
20.5MCall Options Held
11.1KPut Options Held
5.1K-
Baker Bros. Advisors LP New York, NY4.09MShares$27.9 Million0.5% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.89MShares$26.6 Million0.0% of portfolio
-
Artal Group S.A. Luxembourg, N43.08MShares$21 Million1.6% of portfolio
-
Redmile Group, LLC San Francisco, CA3.07MShares$21 Million1.17% of portfolio
-
Goldman Sachs Group Inc New York, NY1.28MShares$8.73 Million0.0% of portfolio
About IGM Biosciences, Inc.
- Ticker IGMS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,969,000
- Market Cap $198M
- Description
- IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...